indirubin has been researched along with Epilepsy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afrikanova, T; Aourz, N; Balegamire, PB; Chabwine, JN; Crawford, AD; de Witte, PAM; Edrada-Ebel, R; Esguerra, CV; Grey, AI; Kamuhabwa, AR; Serruys, AK; Smolders, I; van Leuven, F; Walrave, L | 1 |
1 other study(ies) available for indirubin and Epilepsy
| Article | Year |
|---|---|
Identification of GSK-3 as a Potential Therapeutic Entry Point for Epilepsy.
Topics: Animals; Anticonvulsants; Epilepsy; Glycogen Synthase Kinase 3; Indoles; Male; Mice; Mice, Inbred C57BL; Protein Kinase Inhibitors; Rats; Rats, Wistar; Zebrafish | 2019 |